Location: New York, NY
CIK: 0001017645 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $3.63B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DLO | DLOCAL | 63,906,695 | $725M | 20.0% | — | — | CL A | G29018101 |
| CHYM | CHIME | 19,208,760 | $663M | 18.3% | — | — | COM SHS CL A | 16935C109 |
| ALHC | ALIGNMENT HEALTHCARE | 43,993,323 | $616M | 17.0% | — | — | COM | 01625V104 |
| XP | XP, INC | 25,517,733 | $515M | 14.2% | — | — | CL A | G98239109 |
| — | AKERO THERAPEUTICS | 5,733,989 | $306M | 8.4% | — | — | COM | 00973Y108 |
| ALKT | ALKAMI | 9,645,318 | $291M | 8.0% | — | — | COM | 01644J108 |
| PHVS | PHARVARIS | 7,531,252 | $133M | 3.7% | — | — | COM | N69605108 |
| CNTA | CENTESSA PHARMACEUTICALS | 9,681,818 | $127M | 3.5% | — | — | ADS | 152309100 |
| BULL | WEBULL | 7,148,051 | $85.49M | 2.4% | — | — | ORD SHS | G9572D103 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $73.81M | 2.0% | — | — | CL A | 29882P106 |
| RPRX | ROYALTY PHARMA | 1,500,000 | $54.05M | 1.5% | — | — | CL A | G7709Q104 |
| RSKD | RISKIFIED | 5,324,998 | $26.57M | 0.7% | — | — | CL A | M8216R109 |
| ADAG | ADAGENE | 3,825,952 | $7.461M | 0.2% | — | — | ADS | 005329107 |
| ALMS | ALUMIS | 1,297,530 | $3.893M | 0.1% | — | — | COM | 022307102 |
| GROV | GROVE COLLABORATIVE | 2,474,859 | $2.846M | 0.1% | — | — | CL A | 39957D201 |